Microscale thermophoresis (MST) and TRIC technologies allow you to measure a diverse range of biomolecular interactions in solution, including protein-protein, protein-small molecule, protein-nucleic acid interactions and more.
In this seminar, you will learn how the Monolith (MST) and Dianthus (TRIC) can help you to characterize biomolecular interactions throughout the drug discovery process, from early-stage target identification and understanding disease-related pathways, through to hit screening and lead optimisation.
Dr Claire Hatty is an Application Specialist at NanoTemper Technologies, supporting customers across the UK and Ireland. Claire joined Nanotemper in 2016, after moving to Cambridge, UK from Sydney, Australia in 2014.
Before moving to the UK, Claire completed her PhD at the University of Sydney and Australia Nuclear Science and Technology Organisation (ANSTO), where she studied the structure and interactions of lipid membranes and membrane proteins. She then stayed on as a postdoctoral fellow to study the role of the translocator protein (TSPO) in neuroinflammation.